GALIENI, PIERO
 Distribuzione geografica
Continente #
NA - Nord America 159
EU - Europa 74
AS - Asia 15
Totale 248
Nazione #
US - Stati Uniti d'America 155
IE - Irlanda 15
SE - Svezia 14
UA - Ucraina 14
IT - Italia 13
DE - Germania 7
SG - Singapore 6
CA - Canada 4
DK - Danimarca 4
GB - Regno Unito 4
CN - Cina 3
TR - Turchia 3
FI - Finlandia 2
KR - Corea 2
FR - Francia 1
TW - Taiwan 1
Totale 248
Città #
Chandler 29
Dublin 15
Jacksonville 15
Ashburn 11
Houston 7
Cambridge 6
Ann Arbor 5
Fairfield 5
Lawrence 5
Princeton 5
San Diego 5
Wilmington 5
Boardman 4
New York 4
Ottawa 4
Seattle 4
Beijing 3
Centro 3
Des Moines 3
San Mateo 3
Washington 3
Woodbridge 3
Los Angeles 2
Civitanova Marche 1
London 1
Prescot 1
Turin 1
Totale 153
Nome #
Infections by carbapenem-resistant Klebsiella pneumoniae in SCT recipients: A nationwide retrospective survey from Italy 72
Long-term survival of patients with CLL after allogeneic transplantation: A report from the European Society for Blood and Marrow Transplantation 60
BEEAM (BENDAMUSTINE, ETOPOSIDE, ARA-C, MELPHALAN) PRIOR TO AUTOLOGOUS STEM CELL TRANSPLANT IS SAFE AND EFFECTIVE IN AGGRESSIVE B-CELL NON HODGKIN LYMPHOMA: A PHASE II MULTICENTER STUDY 59
Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study 33
Carfilzomib, cyclophosphamide and dexamethasone for newly diagnosed, high-risk myeloma patients not eligible for transplant: a pooled analysis of two studies 32
Evaluation of Circulating Endothelial Cells as Direct Marker of Endothelial Damage in Allo-Transplant Recipients at High Risk of Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome 1
Totale 257
Categoria #
all - tutte 1.607
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.607


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20191 0 0 0 0 0 0 0 0 0 0 1 0
2019/202019 0 0 2 3 3 0 3 0 3 0 0 5
2020/202144 7 5 5 2 3 4 2 4 3 4 3 2
2021/202229 2 4 2 1 0 1 4 1 4 2 3 5
2022/202387 5 4 10 7 5 13 0 6 26 0 5 6
2023/202444 9 1 4 6 9 10 2 0 0 2 1 0
Totale 257